Testing a new cell-based treatment for IBD in the lab
Part of Digestive system clinical trials.
This study looks at how a special cell product (hAMSC secretome) affects inflammation and scarring in inflammatory bowel disease. Researchers will use your blood and tissue samples to see if it might be a future treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with Crohn's disease or ulcerative colitis.
- You are in remission, newly diagnosed and untreated, have failed at least 2 treatments, or have a fibrostenotic (scarring) form of Crohn's.
- You are willing to provide intestinal biopsy samples and/or blood samples for lab testing.
- You are able to give written consent to use your samples for research.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for specific body signals (called mitochondrial “DAMPs”) that may reflect active inflammation in Crohn’s disease and ulcerative colitis. It also checks how these markers relate to what doctors see during colonoscopy or flexible scope exams, to help understand inflammation and potentially guide future care.
This study checks biomarkers (signals in blood and/or stool) in adults with moderate-to-severe ulcerative colitis. It compares patients starting targeted medicines and looks for marker patterns that may reflect how the disease is behaving.
This study looks at people with active Crohn's disease or ulcerative colitis starting a new type of medication (anti-TNF, ustekinumab, upadacitinib, or vedolizumab), as well as people without IBD having a routine colonoscopy. It aims to collect information to better understand how these treatments work.
This study is looking at people who need an intestinal scope (endoscopy) for gut symptoms or bowel conditions like IBS, IBD, or possible colorectal cancer. Your results may help doctors better understand these long-term conditions and improve follow-up care.
This study collects samples to learn how gut microbes, genetics, and body chemistry may relate to Crohn’s disease or ulcerative colitis. Your information and samples may help researchers understand disease patterns, but it does not test a new drug.
This study collects and stores information and samples from people with inflammatory bowel disease (IBD) to help researchers learn more and improve care. Your participation mainly helps build a “biobank,” which can support future studies.
Hear when a new Inflammatory Bowel Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.